首页>
外国专利>
METHOD FOR PREPARING FLUORINE-18-LABELED FLUOROMETHYL-SUBSTITUTED RADIOPHARMACEUTICALS USING SELECTIVE AZIDE SUBSTITUTION REACTION AND PRECURSOR SCAVENGING
METHOD FOR PREPARING FLUORINE-18-LABELED FLUOROMETHYL-SUBSTITUTED RADIOPHARMACEUTICALS USING SELECTIVE AZIDE SUBSTITUTION REACTION AND PRECURSOR SCAVENGING
A method for preparing a fluorine-18-labeled fluoromethyl-substituted radiopharmaceutical using a selective azide substitution reaction includes (1) obtaining a [18F]fluoride from a cyclotron through an 18O(p,n)18F reaction; (2) separating the [18F] fluoride using an acetonitrile reaction solution containing dissolved K2,2,2 and K2CO3 to obtain a [18F]F−/H218O solution; (3) heating the [18F]F−/H218O solution to obtain K2,2,2/K18F; (4) placing the K2,2,2/K18F along with a bis(tosyloxy)methane compound into a reactor and adding a reaction solvent to cause a reaction and obtain a first precursor solution; (5) cooling the first precursor solution and adding an azide reagent to cause an azide substitution reaction and obtain a [18F]fluoromethyltosylate compound; (6) adding a bioactive molecule to the [18F]fluoromethyltosylate compound to cause an alkylation reaction and obtain a second precursor solution; and (7) adding a precursor scavenger to the second precursor solution and scavenging unreacted precursors to produce a fluorine-18-labeled fluoromethyl-substituted radiopharmaceutical.
展开▼
机译:使用选择性叠氮化物取代反应制备氟-18-标记的氟甲基取代的放射性药物的方法包括(1)通过通过 18加入回旋/ sup的[ 18-sup> f]氟化物> O(p,n) 18 sup> f反应; (2)使用含有溶解的k 2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2 sub> Co f]氟化物分离氟化物> 3 sub>获得[ 18 sup> f] f - sup> / h 2 sub> 18 sup> o溶液; (3)加热[ 18 sup> f] f - sup> / h 2 sub> 18 sup> o溶液,以获得k 2,2,2 sub> / k 18 sup> f; (4)将K 2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,200℃加入反应器中并加入反应溶剂以引起反应并获得第一前体溶液; (5)冷却第一前体溶液并加入叠氮化物试剂以引起叠氮化物取代反应,得到[ 18-sup> f]氟甲基镝化合物; (6)向[ 18℃]氟甲基碳酸溶溶胶化合物中加入生物活性分子以引起烷基化反应并获得第二前体溶液; (7)将前体清除剂添加到第二前体溶液中,并清除未反应的前体,以产生氟-18-标记的氟甲基取代的放射性药物。
展开▼